Reversible inhibitors of monamine oxidase A (RIMA) in the treatment of social phobia

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.5, Iss.3, 1995-09, pp. : 226-226

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selective Serotonin Reuptake Inhibitors in the Treatment of Social Phobia: The Emerging Gold Standard

By Ameringen M.V.

CNS Drugs, Vol. 11, Iss. 4, 1999-04 ,pp. : 307-315

Adis International

Access to resources Recommend Favorite

MAOIs in social phobia

By Katschnig H. Berger P.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 207-207

Elsevier

Access to resources Recommend Favorite

Impaired QOL with social phobia

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 290, 2000-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Dual Inhibitors of Monoamine Oxidase and Cholinesterase for the Treatment of Alzheimer Disease

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 14, 2013-07 ,pp. : 1692-1706

Bentham Science Publishers

Access to resources Recommend Favorite

Leflunomide, a Reversible Monoamine Oxidase Inhibitor

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 16, Iss. 2, 2016-08 ,pp. : 112-119

Bentham Science Publishers

Access to resources Recommend Favorite